Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tooth decay cure? new drug grows dentin in wisdom teeth

NCT ID NCT06580678

Disease control Sponsor: Byoung-Moo Seo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tested a drug called KH001 to see if it could help teeth naturally repair deep cavities. Twelve adults with a decayed wisdom tooth received the treatment. Researchers then checked the teeth for new dentin growth and monitored for side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

12 people

The number who actually took part.

Started

Nov 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 35 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Is between 19 and 35 of age by the time of the screening * Has signed written informed consent in the study * Subject who either have no pain in the affected tooth, or can endure pain until the day of tooth extraction Exclusion Criteria: * Is allergic to the active ingredient or other ingredients used in the investigational product * Have participated in another clinical study within 30 days from screening visit and have a history of administration/application of investigational product/device * Is judged by the investigator as ineligible for participation for other reasens

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dentin caries are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dentin caries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dentin caries

Contacts and locations

Locations

  • Seoul National University Dental Hospital

    Seoul, 03080, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.